ALNOV:EPA
Novacyt
€ 0,45
0,00%
(0,00) 1D
13 nov, 17:35:28 GMT+1 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor ALNOV genereren…
Beursw.
33,95 mln.
Gem. vol.
160,94K
Volume
0,00
52 wk hoog
€ 1,04
52 wk laag
€ 0,29
WPA
€ -0,38
Uitstaande aandelen
72,59 mln.
Aantal medewerkers
228
Beursw.
33,95 mln.
Gem. vol.
160,94K
Volume
0,00
52 wk hoog
€ 1,04
52 wk laag
€ 0,29
WPA
€ -0,38
Uitstaande aandelen
72,59 mln.
Aantal medewerkers
228
Nieuwsartikelen
Van webbronnen en nieuwspartners
Business AM
·
2 dagen geleden
Goldman Sachs verwacht dat de S&P 500 binnen een jaar 8.700 punten bereikt
Yahoo Finance
·
22 minuten geleden
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
TradingView
·
52 minuten geleden
NuRAN Wireless receives Nasdaq minimum bid price deficiency notice
www.marketscreener.com
·
1 uur geleden
Hasko plans to list its shares on Nasdaq Stockholm
Profiel
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Over Novacyt
CEODavid Allmond
Medewerkers228
Opgericht3 jul 2006
Hoofdkantoor-
SectorHealth Care
Industrie-
Websitenovacyt.com